Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis

Blood

Volumn 102, Issue 10, 2003, Pages 3569-3574

  Klippel, Steffen ^b   Strunck, Elisabeth ^b   Temerinac, Snezana ^b   Bench, Anthony J ^b   Meinhardt, Gerold ^b   Mohr, Ursula ^b   Leichtle, Rosi ^b   Green, Anthony R ^b   Griesshammer, Martin ^b   Heimpel, Hermann ^b   Pahl, Heike L ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; POLYCYTHEMIA RUBRA VERA 1; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ERYTHROCYTOSIS; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION PROCESS;

EID: 0242663394     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-03-0919     Document Type: Article

References (36)

1. Carbonell F, Ganser A, Heimpel H. Cytogenetic studies in chronic myeloproliferative diseases. Acta Haematol. 1983;69:145-151.
2. Diez Martin JL, Graham DL, Petitt RM, DeWald GW. Chromosome studies in 104 patients with polycythemia vera. Mayo Clin Proc. 1991;66:287-299.
3. Tefferi A. The Philadelphia chromosome negative chronic myeloproliferative disorders: a practical overview. Mayo Clin Proc. 1998;73:1177-1184.
4. Wasserman LR. The treatment of polycythemia vera. Semin Hematol. 1976;13:57-78.
5. Wasserman LR, Berk PD, Berlin NI. Polycythemia vera and the myeloproliferative disorders. Philadelphia, PA: WB Saunders; 1995.
6. Pearson TC, Messinezy M. The diagnostic criteria of polycythaemia rubra vera. Leuk Lymph. 1996; 22(suppl 1):87-93.
7. Tefferi A. Diagnosing polycythemia vera: a paradigm shift. Mayo Clin Proc. 1999;74:159-162.
8. WHO: Tumours of the Hemopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
9. Pearson TC. Evaluation of diagnostic criteria in polycythemia vera. Semin Hematol. 2001;38: 21-24.
10. Prchal JF, Axelrad AA. Bone-marrow responses in polycythemia vera [letter]. N Engl J Med. 1974; 290:1382.
11. Eaves AC, Henkelman DH, Eaves CJ. Abnormal erythropoiesis in the myeloproliferative disorders: an analysis of underlying cellular and humoral mechanisms. Exp Hematol. 1980;8:235-247.
12. Weinberg RS, Worsley A, Gilbert HS, Cuttner J, Berk PD, Alter BP. Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia: only polycythemia vera has endogenous colonies. Leuk Res. 1989;13:331-338.
13. Lemoine F, Najman A, Baillou C, et al. A prospective study of the value of bone marrow erythroid progenitor cultures in polycythemia. Blood. 1986; 68:996-1002.
14. Westwood N, Dudley JM, Sawyer B, Messinezy M, Pearson TC. Primary polycythaemia: diagnosis by non-conventional positive criteria. Eur J Haematol. 1993;51:228-232.
15. Shih LY, Lee CT, Ou YC. Prediction of clinical course in patients with idiopathic erythrocytosis by endogenous erythroid colony assay but not by serum erythropoietin levels. Exp Hematol. 1997; 25:288-292.
16. Shih LY, Lee CT, See LC, et al. In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia. Eur J Clin Invest. 1998;28:569-576.
17. Temerinac S, Klippel S, Strunck E, et al. Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in Polycythemia rubra vera. Blood. 2000;95:2569-2576.
18. Kruisbeck AM, Margulies DH, Shevach EM, Strober W. Current Protocols in Immunology. Hoboken, NJ: Wiley, 1991.
19. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics. East Norwalk, CT: Appleton and Lange; 1994.
20. Brohee D, Vanuffel P, Ravoet C, et al. Correlation of PRV-1 expression with clinical diagnosis on myeloproliferative syndromes [abstract]. Blood. 2002;100:3146a.
21. Spinelli O, Rota B, Finazzi G, Barbui T, Rambaldi A. Quantitative analysis of PRV-1 gene expression in chronic myeloproliferative disorders: positive correlation with polycythemia vera diagnosis and leukocyte alkaline phosphatase expression [abstract]. Blood. 2002;100:3145a.
22. Ricksten A, Palmquist L, Wasslavik C, et al. High PRV-1 mRNA expression, a diagnostic marker for polycythemia vera [abstract]. Blood. 2002;100: 3156a.
23. Bux J, Goehring K, Wolff J, et al. Expression of NB1 glycoprotein (HNA-2A, CD177) on neutrophils is upregulated in inflammatory diseases and during G-CSF treatment [abstract]. Blood. 2002; 100:1794a.
24. Kralovics R, Buser AS, Teo S-S, et al. Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders. Blood. Prepublished online on May 1, 2003, as DOI 10.1182/blood-2003-03-0744.
25. Liu E, Jelinek J, Pastore YD, Guan Y, Prchal JF, Prchal JT. Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood. 2003;101:3294-3301.
26. Moliterno AR, Hankins D, Spivak JL. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med. 1998;338:572-580.
27. Moliterno AR, Siebel KE, Sun AY, Hankins WD, Spivak JL. A novel thrombopoietin signaling defect in polycythemia vera platelets. Stem Cells. 1998;16:185-192.
28. Moliterno AR, Silver RT, Spivak JL. A diagnostic assay for polycythemia vera [abstract]. Blood. 2000;96:512a.
29. Le Blanc K, Andersson P, Samuelsson J. Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c-mpl in polycythaemia vera. Brit J Haematol. 2000;108: 80-85.
30. Harrison CN, Gale RE, Pezella F, Mire-Sluis A, Machin SJ, Linch DC. Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value. Brit J Haematol. 1999;107:139-147.
31. Berlin NI, Lewis SM. Measurement of total RBC volume relative to lean body mass for diagnosis of polycythemia. Am J Clin Pathol. 2000;114:922-926.
32. Spivak JL. Polycythemia vera: myths, mechanisms, and management. Blood. 2002;100:4272-4290.
33. Fruehauf S, Topaly J, Villalobos M, et al. Uniform decrease of the initially upregulated polycythemia rubra vera-1 (PRV-1) gene mRNA expression in granulocytes of polycythemia vera patients treated with interferon-alpha [abstract]. Blood. 2002;100:3154a.
34. Klippel S, Strunck E, Temerinac S, et al. Quantification of PRV-1 expression, a molecular marker for the diagnosis of polycythemia vera [abstract]. Blood. 2001;98:470a.
35. Shih L-Y, Lee C-T. Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay. Blood. 1994;83:744-748.
36. Griesshammer M, Hochhaus A. Chronische myeloproliferative Erkrankungen. In: Classen M, Dierkesmann R, Heimpel H, Specker JR, Koch KM, Meyer J, eds. Rationelle Diagnostik und Therapie in der Inneren Medizin. München, Germany: Urban und Fischer; 2002;B8:1-11.